SUBSCRIBE
SUBSCRIBE
News   Drug Development

Mesoblast Limited Interview With MD Silviu Itescu On Angioblast - Progression of Four Phase 2 Trial Applications

September 1, 2009 | 
1 min read

Melbourne, Sep 1, 2009 (ABN Newswire) - Mesoblast Limited (ASX:MSB)(PINK:MBLTY) is pleased to provide an interview with MD Silviu Itescu on its United States-based associate company Angioblast Systems Inc.

Clinical research Phase II Asia Australia
MORE ON THIS TOPIC
vintage textured collage with symbols of New York City
Tariffs
Biotech’s Next Phase Will Be All-American: Pitchbook
April 17, 2025
 · 
2 min read
 · 
Annalee Armstrong
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Artificial intelligence
Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics
April 17, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Profit and Money Concept, Financial and Business Graph
GLP-1
Lilly Skyrockets on ‘Injectable-Like Efficacy’ for Oral GLP-1 in Phase III Diabetes Trial
April 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Lungs health and pulmonology as a respiratory medicine conept for pulmonary science and lung cancer or respiration disease and bronchi breathing or asthma symbol in a 3D illustration style.
Clinical research
Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II
April 16, 2025
 · 
2 min read
 · 
Tristan Manalac